- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Steroid dependent or steroid intolerant or steroid refractory chronic graft versus host disease (cGVHD)
- Meeting Date: September 2021
- Public Summary Document (PSD) September 2021 PBAC Meeting - (PDF 440KB)
- Public Summary Document (PSD) September 2021 PBAC Meeting - (Word 71KB)
Methoxsalen – September 2021
Methoxsalen: Solution for blood fraction 20 microgram per mL, 10 mL; Uvadex®
Last updated
24 December 2021